Periprosthetic joint infection of a total hip arthroplasty with Candida parapsilosis

Laurence Vergison1, Alexander Schepens2, Koen Liekens2

  • 1Department of Orthopaedic Surgery and Traumatology, General Hospital St-Lucas, Ghent, Belgium; Department of Orthopaedic Surgery and Traumatology, Ghent University Hospital, Ghent, Belgium.

Abstract

Insights

Fungal periprosthetic joint infection (PJI) after total hip arthroplasty (THA) requires prompt diagnosis and treatment. This case highlights successful two-stage revision surgery and long-term fluconazole therapy for Candida parapsilosis PJI.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Mycology

Background:

  • Fungal periprosthetic joint infection (PJI) is a rare but serious complication following joint arthroplasty.
  • Candida parapsilosis is an opportunistic fungal pathogen that can cause PJI.

Observation:

  • A 73-year-old woman developed PJI with Candida parapsilosis one month after total hip arthroplasty (THA).
  • Initial presentation included difficulty walking and mildly elevated inflammatory markers.

Findings:

  • Diagnosis was confirmed by aspirating a subcutaneous abscess, identifying Candida parapsilosis.
  • A two-stage revision arthroplasty without a spacer was performed, combined with a six-week prosthesis-free interval.
  • Intravenous and subsequent lifelong oral fluconazole therapy was administered.

Implications:

  • Early joint aspiration is crucial for diagnosing suspected PJI.
  • Two-stage revision arthroplasty with systemic antifungal therapy is an effective treatment for fungal PJI.
  • Long-term fluconazole treatment, at least six months, is recommended for successful outcomes.